Robert Mull

1.5k total citations
30 papers, 1.1k citations indexed

About

Robert Mull is a scholar working on Public Health, Environmental and Occupational Health, Organic Chemistry and Oncology. According to data from OpenAlex, Robert Mull has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 6 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Robert Mull's work include Malaria Research and Control (11 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Computational Drug Discovery Methods (4 papers). Robert Mull is often cited by papers focused on Malaria Research and Control (11 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Computational Drug Discovery Methods (4 papers). Robert Mull collaborates with scholars based in Switzerland, Thailand and Netherlands. Robert Mull's co-authors include J Karbwang, Farkad Ezzet, Insa Gathmann, A. J. Plummer, Joachim Richter, Michiel A. van Agtmael, Udomsak Silachamroon, S Looareesuwan, S Krudsood and Sombat Treeprasertsuk and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Robert Mull

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Mull Switzerland	16	667	296	256	155	117	30	1.1k
S Vanijanonta Thailand	23	1.2k 1.8×	345 1.2×	302 1.2×	248 1.6×	83 0.7×	47	1.5k
Heinrich Urwyler Switzerland	12	686 1.0×	106 0.4×	260 1.0×	90 0.6×	327 2.8×	13	1.3k
Sarah Arbe‐Barnes Switzerland	10	571 0.9×	129 0.4×	251 1.0×	96 0.6×	177 1.5×	16	880
Melvin H. Heiffer United States	11	424 0.6×	186 0.6×	176 0.7×	45 0.3×	130 1.1×	33	758
G. P. Dutta India	17	606 0.9×	109 0.4×	100 0.4×	135 0.9×	276 2.4×	109	1.0k
L Phaipun Thailand	14	1.8k 2.7×	434 1.5×	476 1.9×	293 1.9×	134 1.1×	14	2.0k
P.A. Winstanley United Kingdom	17	994 1.5×	260 0.9×	170 0.7×	168 1.1×	129 1.1×	33	1.4k
P Charoenlarp Thailand	15	435 0.7×	144 0.5×	103 0.4×	104 0.7×	75 0.6×	45	878
Paktiya Teja‐Isavadharm Thailand	21	958 1.4×	348 1.2×	326 1.3×	290 1.9×	140 1.2×	36	1.3k
W.H. Wernsdorfer Austria	22	1.2k 1.8×	294 1.0×	245 1.0×	148 1.0×	92 0.8×	49	1.4k

Countries citing papers authored by Robert Mull

Since Specialization

Citations

This map shows the geographic impact of Robert Mull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Mull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Mull more than expected).

Fields of papers citing papers by Robert Mull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Mull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Mull. The network helps show where Robert Mull may publish in the future.

Co-authorship network of co-authors of Robert Mull

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Mull. A scholar is included among the top collaborators of Robert Mull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Mull. Robert Mull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lintelo, Dolf te, et al.. (2023). Protracted displacement and housing systems in intermediary cities: the case of Syrians in Torbalı, Türkiye. International Journal of Housing Policy. 25(2). 279–303. 3 indexed citations

Lintelo, Dolf te, et al.. (2022). Displacement and placemaking in design studios. SHILAP Revista de lepidopterología. 21(1). 3 indexed citations

Dumez, Herlinde, A.T. van Oosterom, J. D. Rothermel, Robert Mull, & A H Calvert. (2004). Phase Ib/II dose-escalation trial evaluating the safety and tolerability of EPO906 plus capecitabine in patients with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 2093–2093. 5 indexed citations

Looareesuwan, S, Sombat Treeprasertsuk, S Krudsood, et al.. (2001). A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.. American Journal of Tropical Medicine and Hygiene. 64(5). 247–256. 149 indexed citations

Vugt, Michèle van, S. Looareesuwan, Polrat Wilairatana, et al.. (2000). Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 94(5). 545–548. 120 indexed citations

Mull, Robert, et al.. (2000). The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection.. American Journal of Tropical Medicine and Hygiene. 63(5). 264–269. 53 indexed citations

Kshirsagar, N A, M. R. Garg, S S Dalvi, et al.. (2000). A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India.. American Journal of Tropical Medicine and Hygiene. 62(3). 402–408. 35 indexed citations

Na‐Bangchang, K, et al.. (1999). Pharmacokinetics of benflumetol given as a fixed combination artemether-benflumetol (CGP 56697) in Thai patients with uncomplicated falciparum malaria.. PubMed. 19(2). 41–6. 5 indexed citations

Agtmael, Michiel A. van, et al.. (1999). Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria. International Journal of Antimicrobial Agents. 12(2). 151–158. 77 indexed citations

10.

Agtmael, Michiel A. van, Olivier Bouchaud, Denis Malvy, et al.. (1999). The comparative efficacy and tolerability of CGP 56697 (artemether+lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France. International Journal of Antimicrobial Agents. 12(2). 159–169. 45 indexed citations

11.

Richter, Joachim, et al.. (1999). Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole. Tropical Medicine & International Health. 4(11). 774–781. 40 indexed citations

12.

Mull, Robert, et al.. (1998). Positioning, labelling, and medical information control of co-artemether tablets (CPG 56697): a fixed novel combination of artemether and benflumetol. Novartis Co-Artemether International Development Team.. PubMed. 58(3 Suppl). 77–81. 9 indexed citations

13.

Lecaillon, J. B., J. Godbillon, Joelle Campestrini, et al.. (1998). Effect of food on the bioavailability of triclabendazole in patients with fascioliasis. British Journal of Clinical Pharmacology. 45(6). 601–604. 43 indexed citations

14.

Felger, Ingrid, Salim Abdulla, Thomas A. Smith, et al.. (1998). Distinction of recrudescences from new infections by pcr‐rflp analysis in a comparative trial of cgp 56 697 and chloroquine in Tanzanian children.. Tropical Medicine & International Health. 3(6). 490–497. 48 indexed citations

15.

Ezzet, Farkad, Robert Mull, & J Karbwang. (1998). Population pharmacokinetics and therapeutic response of CGP 56697 (artemether+benflumetol) in malaria patients. British Journal of Clinical Pharmacology. 46(6). 553–561. 178 indexed citations

16.

Hatz, Christoph, Salim Abdulla, Robert Mull, et al.. (1998). Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1–5 years. Tropical Medicine & International Health. 3(6). 498–504. 83 indexed citations

17.

Mull, Robert, et al.. (1988). Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignancies.. PubMed. 1(1). 21–9. 8 indexed citations

18.

Mull, Robert, et al.. (1962). Guanidines with Antihypertensive Activity. II. Journal of Medicinal Chemistry. 5(5). 944–949. 9 indexed citations

19.

Mull, Robert, et al.. (1960). Guanidines with Antihypertensive Activity. The Journal of Organic Chemistry. 25(11). 1953–1956. 12 indexed citations

20.

Huebner, Charles F., et al.. (1953). A NEW CLASS OF ANTITUBERCULAR COMPOUNDS. Journal of the American Chemical Society. 75(9). 2274–2275. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact